In the public interest?
Where this comes from
- Record sourced from PubMed, PMID 22837535.
- Also identified by DOI 10.1126/scitranslmed.3003612.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Restrictive patenting and licensing for cell-free fetal DNA testing has serious consequences for technology advances and benefits to public health.
Medical subject headings
- DNA
- Prenatal Diagnosis